Konica develops test for ovarian cancer
This article was originally published in Clinica
Executive Summary
Konica has begun marketing in Japan an enzyme immunoassay test that measures galactose transferase, a marker for ovarian cancer. GAT measurement can be used to follow cancer treatment and check for its recurrence and to distinguish between ovarian cancer and an endometrial ovarian cyst.